Recombinant Human UPF0414 transmembrane protein C20orf30 (C20orf30)

Basic Research Questions

• What is the molecular structure and basic characteristics of TMEM230/C20orf30?

  TMEM230, also known as C20orf30, is a transmembrane protein primarily localized in synaptic vesicles in neurons. The protein has the following characteristics:

  Parameter	Value
  Sequence Length (AA)	120
  Molecular Weight (Da)	13,188
  Official Gene Symbol	TMEM230
  Other Aliases	C20orf30
  Gene ID (NCBI)	29058

  The protein sequence begins with "MMPSRTNLAT GIPSSKVKYS RLSSTDDGYI DLQFKKTPPK IPYKAIALAT" and contains two isoforms produced by alternative splicing . TMEM230 is primarily a transmembrane protein found in synaptic vesicles, and disease-linked mutations in this protein have been associated with Parkinson's disease through impaired synaptic vesicle trafficking .

• What standard experimental methods are commonly used to detect and analyze TMEM230?

  Several experimental methods are used for TMEM230 detection and analysis:

  Application	Methodology	Dilution/Parameters
  Western Blot (WB)	Antibody detection	1:1000-1:4000
  Immunohistochemistry (IHC)	Tissue visualization	1:50-1:500
  Immunofluorescence (IF)	Cellular localization	As cited in publications
  ELISA	Protein quantification	Various kits available

  For phosphorylation detection, the Fred Hutchinson Cancer Research Center has developed an assay (CPTAC-960) for detecting phosphorylation at S24, using IMAC (Immobilized Metal Affinity Chromatography) enrichment coupled with Multiple Reaction Monitoring (MRM) . This technique enables reproducible quantification of phospho-signaling.

• How are recombinant versions of TMEM230/C20orf30 produced and stored?

  Recombinant TMEM230 protein can be produced using several expression systems:

  Expression System	Applications	Purity
  E. coli	Basic protein studies	≥85%
  Yeast	Post-translational modifications	≥85%
  Baculovirus	Eukaryotic modifications	≥85%
  Mammalian Cell	Native-like folding	≥85%
  Cell-Free Expression	Rapid production	≥85%

  For storage, the recommended conditions are -20°C for long-term storage, with -80°C for extended periods. Working aliquots can be stored at 4°C for up to one week. Repeated freezing and thawing is not recommended as it may affect protein stability and activity .

Advanced Research Questions

• What experimental design considerations are important when studying TMEM230's role in neurodegeneration?

  When designing experiments to study TMEM230's role in neurodegeneration, researchers should consider:

  1. Variable control: Define clear independent variables (e.g., TMEM230 mutations, expression levels) and dependent variables (e.g., vesicle trafficking metrics, neuronal viability) .

  2. Model selection: Choose appropriate models ranging from cell lines (HEK-293, HeLa, neuronal cell lines) to animal models with consideration of species differences in TMEM230 function .

  3. Temporal dynamics: Implement time-series experimental designs to capture progressive effects of TMEM230 dysfunction, as neurodegenerative processes develop over time .

  4. Control groups: Include both positive controls (known disease-causing mutations) and negative controls (wild-type TMEM230) .

  5. Co-localization studies: Design experiments to evaluate TMEM230 interaction with syntaxin 6 (STX6) in the trans-Golgi network and other relevant trafficking proteins .

  The relationship between TMEM230 mutations and Parkinson's disease was established through rigorous experimental design including genome-wide linkage analysis with multiple microsatellite markers, which yielded two-point LOD scores over 3.3 and multi-point scores over 3.8 for markers on chromosome 20 .

• How can researchers resolve contradictory findings in TMEM230 functional studies?

  Contradiction resolution in TMEM230 research requires systematic approaches:

  1. Sparse-Aware Analytical Methods: Recent studies have developed "SparseCL" approaches, which utilize specially trained sentence embeddings to identify contradictions in research data. This method combines cosine similarity metrics with sparsity functions to efficiently detect contradictory findings across large document corpora .

  2. Mixed Methods Approach: Combine qualitative and quantitative research methods to triangulate findings. For example, when studying TMEM230's role in vesicle trafficking, complement quantitative trafficking assays with qualitative immunofluorescence visualization .

  3. Systematic Variable Isolation: When contradictory results appear, systematically isolate variables by:

     • Testing different antibody clones and dilutions

     • Comparing expression systems (bacterial vs. mammalian)

     • Evaluating cell-type specific effects

     • Controlling for post-translational modifications

  4. Meta-analytical Framework: Apply formal meta-analytical techniques to integrate contradictory findings across studies, weighting results by methodological rigor and sample size .

• What methodological approaches are recommended for studying TMEM230's interactions with other proteins?

  To study TMEM230's protein interactions, researchers should consider these methodological approaches:

  1. RNA-binding protein immunoprecipitation (RIP) coupled with microarray analysis: Similar to methods used for studying Musashi1 downstream targets, this approach can identify RNA interactions of TMEM230 .

  2. Co-immunoprecipitation protocol:

     • Isolate RNP complexes using appropriate buffers (e.g., NT2 buffer)

     • Perform SDS-PAGE separation

     • Conduct Western blots with specific antibodies

     • For precipitation Western blots, re-suspend beads in SDS-loading buffer and heat at 95°C for 10 minutes before analysis

  3. Subcellular co-localization studies:

     • Test markers for different organelles (mitochondria, lysosomes, endoplasmic reticulum)

     • Evaluate Golgi apparatus markers like GOLGA2 (cis-Golgi matrix protein)

     • Assess co-localization with transmembrane proteins like syntaxin 6 (STX6) in the trans-Golgi network

  4. Phosphorylation analysis: Use enrichment methods like IMAC coupled to multiple reaction monitoring for detecting phosphorylation states, as has been established in the CPTAC-960 assay for the S24 phosphorylation site .

• What considerations should guide experimental design when testing TMEM230 variants across different species?

  When designing cross-species experiments for TMEM230 research:

  1. Sequence homology analysis: Compare TMEM230 sequences across species to identify conserved domains that might be functionally critical. Available recombinant proteins from multiple species (human, rat, mouse, chicken, bovine) facilitate comparative studies .

  2. Expression pattern comparison: Design experiments to compare tissue-specific expression patterns across species using equivalent detection methods (e.g., standardized IHC protocols) .

  3. Functional conservation testing: Implement rescue experiments where the human TMEM230 is expressed in model organisms with knocked-out endogenous TMEM230 to test functional conservation.

  4. Species-specific post-translational modifications: Design protocols to identify species-specific differences in phosphorylation, glycosylation, or other modifications that might affect function.

  5. Experimental control design: When comparing across species, ensure proper controls by:

     • Using both between-subjects and within-subjects designs where appropriate

     • Applying counterbalanced designs to control for order effects

     • Implementing equivalent time-samples design when temporal effects are important

• How can advanced data analysis techniques be applied to TMEM230 experimental results?

  Advanced data analysis for TMEM230 research includes:

  1. Microarray data analysis workflow:

     • Quality evaluation through diagnostic plots and hierarchical clustering

     • Background correction using "normexp + offset" method

     • Within-arrays normalization using "loess" method

     • Between-arrays normalization using "Aquantile" method

     • Differential expression assessment through linear models and Bayes' methods (LIMMA model)

     • Establishing thresholds (e.g., 2-fold enrichment/reduction with adjusted FDR p-values below 0.05)

  2. Quantitative phosphoproteomics:

     • Implement IMAC-MRM (Immobilized Metal Affinity Chromatography coupled to Multiple Reaction Monitoring)

     • Establish standard curves using synthetic peptides

     • Normalize data using internal standards labeled with 13C and 15N

     • Apply appropriate statistical models for phosphorylation site occupancy

  3. Genetic linkage analysis:

     • Calculate LOD scores for genetic markers (scores >3.3 for two-point analysis and >3.8 for multi-point analysis are significant)

     • Construct genetic haplotypes to identify disease-associated variants

     • Define minimum candidate regions through analysis of crossover events

Research Application Questions

• What are the most effective experimental approaches for evaluating TMEM230's role in Parkinson's disease?

  Effective experimental approaches include:

  1. Family-based genetic studies: Collect DNA samples from affected families and perform genome-wide linkage analysis using microsatellite markers, as demonstrated in studies that identified TMEM230 mutations in familial Parkinson's disease .

  2. Cellular trafficking assays: Design experiments to quantify vesicle trafficking efficiency in cells expressing wild-type versus mutant TMEM230, focusing on:

     • Vesicle formation rates

     • Trafficking velocities

     • Fusion events

     • Recycling efficiency

  3. Transgenic animal models: Develop animal models expressing Parkinson's disease-associated TMEM230 mutations to study:

     • Age-dependent neurodegeneration

     • Motor function deficits

     • Response to therapeutic interventions

  4. Structural biology approaches: Implement techniques to understand how disease-associated mutations alter TMEM230 structure and function.

  These approaches should be designed with appropriate controls, multiple technical and biological replicates, and blinded assessment of outcomes to ensure reliability and validity .

• How can researchers design experiments to identify novel functions of TMEM230/C20orf30?

  To identify novel TMEM230 functions, design experiments that:

  1. Employ unbiased interaction screens:

     • Yeast two-hybrid screening

     • BioID proximity labeling

     • Mass spectrometry-based interactome analysis

     • RNA-seq following TMEM230 manipulation

  2. Utilize CRISPR-Cas9 screening:

     • Design genome-wide or pathway-focused CRISPR libraries

     • Screen for phenotypes after TMEM230 knockout in various cellular contexts

     • Validate hits with individual knockout/knockdown experiments

  3. Implement time-series experimental designs:

     • Monitor changes in cellular processes following inducible TMEM230 expression

     • Capture temporal dynamics of responses to identify primary versus secondary effects

     • Apply appropriate statistical tests for time-series data

  4. Develop tissue-specific conditional knockout models:

     • Generate animal models with conditional TMEM230 deletion

     • Systematically characterize phenotypes across tissues and developmental stages

     • Apply factorial experimental designs to test interactions with environmental factors

• What methodological considerations are important when performing phosphorylation studies on TMEM230?

  For phosphorylation studies of TMEM230:

  1. Site identification strategy:

     • Use phospho-specific antibodies for known sites (e.g., S24)

     • Employ mass spectrometry for unbiased phosphosite mapping

     • Utilize prediction algorithms to identify potential kinase recognition motifs

  2. Enrichment techniques:

     • IMAC (Immobilized Metal Affinity Chromatography) for phosphopeptide enrichment

     • Titanium dioxide (TiO₂) chromatography as an alternative approach

     • Phospho-specific antibody immunoprecipitation for targeted analyses

  3. Quantification methods:

     • Multiple Reaction Monitoring (MRM) for targeted quantification

     • Parallel Reaction Monitoring (PRM) for improved selectivity

     • Label-free or isotope labeling strategies (SILAC, TMT, iTRAQ)

  4. Biological significance assessment:

     • Mutation of phosphosites to non-phosphorylatable residues (e.g., S→A)

     • Phosphomimetic mutations (e.g., S→D or S→E)

     • Pharmacological manipulation of relevant kinases and phosphatases

  The assay developed by the Fred Hutchinson Cancer Research Center (CPTAC-960) provides a specific protocol for detecting phosphorylation at S24 of TMEM230 using an enrichment MRM approach with IMAC .